Cytotoxicity of a novel oil/water microemulsion system loaded with mitomycin-C in in vitro lung cancer models

Drug Development Research

Volumn 73, Issue 4, 2012, Pages 185-195

  Kotmakchiev, Mustafa ^a   Kantarci, Gülten ^a   Çetinta̧s, Vildan B ^a   Ertan, Gökhan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

A549; Calu1; Microemulsion; Mitomycin C

Indexed keywords

ALCOHOL; MITOMYCIN C; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; SODIUM CHLORIDE; SOYBEAN OIL; WATER;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONDUCTANCE; CONTROLLED STUDY; CYTOTOXICITY; DRUG RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; MICROEMULSION; PARTICLE SIZE; STORAGE; VISCOSITY;

EID: 84862851679     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.21007     Document Type: Article

References (43)

1. Allan L, Cummings J, Willmott N, Whateley TL, Smyth JF. 1993. Incorporation and release of chemically intact mitomycin C from albumin microspheres: a high performance liquid chromatography evaluation. J Drug Target 1:317-323. (Pubitemid 2038376)
2. Almond BA, Hadba AR, Freeman ST, Cuevas BJ, York AM, Detrisac CJ, Goldberg EP. 2003. Efficacy of mitoxantrone-loaded albumin microspheres for intratumoral chemotherapy of breast cancer. J Control Release 91:147-155. (Pubitemid 37288885)
3. Aparicio RM, García-Celma MJ, Vinardell MP, Mitjans M. 2005. In vitro studies of the hemolytic activity of microemulsions in human erythrocytes. J Pharm Biomed Anal 39:1063-1067. (Pubitemid 41441739)
4. Bligh HFJ, Bartoszek A, Robson CN, Hickson ID, Kasper CB, Beggs JD, Wolf DJ. 1990. Activation of mitomycin C by NADPH: cytochrome P-450 reductase. Cancer Res 50:7789-7792.
5. Boamah EK, White DE, Talbott KE. 2007. Mitomycin-DNA adducts induce p53-dependent and p53-independent cell death pathways. ACS Chem Biol 2:399-407. (Pubitemid 350010544)
6. Bradner WT. 2001. Mitomycin C: a clinical update. Cancer Treat Rev 27:35-50. (Pubitemid 32229684)
7. Caamano J, Ruggeri B, Momiki S, Sickler A, Zhang SY, Klein-Szanto AJ. 1991. Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines. Am J Pathol 139:839-845.
8. Çelikoǧlu SI, Karayel T, Demirci S, Çelikoǧlu F, Çaǧatay T. 1997. Direct injection of anti-cancer drugs into endobronchial tumours for palliation of major airway obstruction. Postgrad Med J 73:159-162.
9. Çelikoǧlu SI, Çelikoǧlu F, Goldberg PG. 2006. Endobronchial intratumoral chemotherapy (EITC) followed by surgery in early non-small cell lung cancer with polypoid growth causing erroneous impression of advanced disease. Lung Cancer 54:339-346.
10. Cho Y-H, Kim S, Bae EK, Mok CK, Park J. 2008. Formulation of a cosurfactant-free o/w microemulsion using nonionic surfactant mixtures. J Food Sci 73:E115-E121. (Pubitemid 351489968)
11. Date AA, Nagarsenker MJ. 2008. Parenteral microemulsions: an overview. Int J Pharm 355:19-30.
12. Den Hartigh J, McVie JG, van Oort WJ, Pinedo HM. 1983. Pharmacokinetics of mitomycin C in humans. Cancer Res 43:5017-5021. (Pubitemid 13015890)
13. Djordjevic L, Primorak M, Stupar M. 2005. In vitro release of diclofenac diethylamine from caprylocaproyl macrogolglycerides based microemulsions. Int J Pharm 296:73-79. (Pubitemid 40693374)
14. Ege MA, Karasulu HY, Guneri T. 2004. Triangle phase diagram analysis software. The 4th International Postgraduate Research Symposium on Pharmaceutics, Istanbul 20-22 September 2004.
15. Emanuel MN, Bogdanov GN, Orlov SV. 1984. Free-radical mechanisms in the cytotoxic action of antitumour antibiotics. Russian Chem Rev 53:1121-1138. (Pubitemid 15006167)
16. Garadzielsky M. 2008. Recent developments in the characterization of microemulsions. Curr Opin Colloid Interface Sci 13:263-269.
17. Hou Z, Wei H, Wang Q, Sun Q, Zhou C, Zhan C, Tang X, Zhang Q. 2009. New method to prepare mitomycin C loaded PLA-nanoparticles with high drug entrapment efficiency. Nanoscale Res Lett 4:732-737.
18. Ishii F, Nagasaka Y. 2004. Interaction between erythrocytes and free phospholipids as an emulsifying agent in fat emulsions or drug carrier emulsions for intravenous injections. Colloid Surface B Biointerfaces 37:43-47.
19. Iyer VN, Szybalski W. 1964. Mitomycin C and porfiromycin: chemical mechanism of activation and cross-linking of DNA. Science 145:55-58.
20. Jumaa M, Müller BW. 2000. Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of the protective effect. Eur J Pharm Sci 9:285-290.
21. Kantarci G, Özgüney I, Karasulu HY, Arzik S, Güneri T. 2007. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies. AAPS PharmSciTech 8(4):E1-E7. Article 91.
22. Karasulu HY, Karabulut B, Kantarci G, Ozgüney I, Sezgin C, Sanli UA, Göker E. 2004. Preparation of arsenic trioxide-loaded microemulsion and its enhanced cytotoxicity on MCF-7 breast carcinoma cell line. Drug Deliv 11:345-350.
23. Karasulu HY, Kantarci G, Karaca B, Armagan V, Güneri T, Göker E. 2009. Determining the cytotoxicity of methotrexate-loaded microemulsion on human breast, ovarian, and prostate carcinoma cell lines: a new modality for an old drug. Drug Dev Res 70:49-56.
24. Krzyzaniak JF, Alvarez Núñez FA, Raymond DM, Yalkowsky SH. 1997a. Lysis of human red blood cells 4: comparison of in vitro and in vivo hemolysis data. J Pharm Sci 86:1215-1217. (Pubitemid 27486089)
25. Krzyzaniak JF, Raymond DM, Yalkowsky SH. 1997b. Lysis of human red blood cells 2: effect of contact time on cosolvent induced hemolysis. Int J Pharm 152:193-200. (Pubitemid 27290593)
26. Lain S, Lane D. 2003. Improving cancer therapy by non-genotoxic activation of p53. Eur J Cancer 39:1053-1060. (Pubitemid 36555861)
27. Levine AJ, Momand J, Finlay CA. 1991. The p53 tumor suppressor gene. Nature 351:453-456.
28. Lv F-F, Zheng L-Q, Tung C-H. 2005. Phase behaviour of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system. Int J Pharm 301:237-246. (Pubitemid 41206608)
29. Narain PK, DeMaria EJ, Heuman DM. 1998. Lecithin protects against plasma membrane disruption by bile salts. J Surg Res 78:131-136. (Pubitemid 28419223)
30. Nomura T, Saikawa A, Morita S Kakutani TS, Yamashita F, Honda K, Takakura Y, Hashida M. 1998. Pharmacokinetic characteristics and therapeutic effects of mitomycin C-dextran conjugates after intratumoral injection. J Control Release 52:239-252. (Pubitemid 28135253)
31. Park K-M, Lee M-K, Hwang K-J, Kim C-K. 1999. Phospholipid-based microemulsions of flurbiprofen by spontaneous emulsification process. Int J Pharm 183:145-154. (Pubitemid 29257960)
32. Pestana KC, Formariz TP, Franzini CM, Sarmento VHV, Chiavacci LA, Scarpa MV, Egito EST, Oliveira AG. 2008. Oil-in-water lecithin-based microemulsions as potential delivery systems for amphotericin B. Colloid Surface B Biointerfaces 66:253-259.
33. Pirnia F, Schneider E, Betticher DC, Borner MM. 2002. Mitomycin C induces apoptosis and caspase-8 and -9 processing through acaspase-3 and Fas-independent pathway. Cell Death Differ 9:905-914. (Pubitemid 35023606)
34. Reed KW, Yalkowsky SH. 1985. Lysis of human red blood cells in the presence of various cosolvents. J Parenter Sci Technol 39:64-68.
35. Rump AF, Woschée U, Theisohn M, Fischbach R, Heindel W, Lackner K, Klaus W. 2002. Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheres. Eur J Clin Pharmacol 58:459-465. (Pubitemid 35244919)
36. Sasaki H, Kakutani T, Hashida M, Sezaki H. 1985. Absorbtion characteristics of the lipophilic prodrug of mitomycin C from injected liposomes or an emulsion. J Pharm Pharmacol 37:461-465. (Pubitemid 15042937)
37. Shiokawa T, Hattori Y, Kawano K, Ohguchi Y, Kawakami H, Toma K, Maitani Y. 2005. Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo. Clin Cancer Res 11:2018-2025. (Pubitemid 40471868)
38. Shitara K, Ikami I, Munakata M, Muto O, Sakata Y. 2008. Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma. Clin Oncol 20:241-246.
39. Tomasz M, Lipman R, Chowdary D, Pawlak J, Verdine GL, Nakanishi K. 1987. Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science 235:1204-1208. (Pubitemid 17034007)
40. Wagai F, Kinoshita R, Watanabe RSH, Kitamura S. 1981. The direct injection of several anti-cancer drugs into the primary lung cancer through a fiberoptic bronchoscope. In: Nandi PI, Lam WK, editors. Proceedings of Seventh Asia Pacific Congress on Diseases of the Chest. Tokyo: University of Tokyo Faculty of Medicine, p 448-450.
41. Witthayapanyanon A, Phan TT, Heitmann TC, Harwell JH, Sabatini DA. 2010. Interfacial properties of extended surfactant-based microemulsions and related macroemulsions. J Surfact Deterg 13:127-134.
42. Yalkowsky SH, Krzyzaniak JF, Ward GH. 1998. Formulation-related problems associated with intravenous drug delivery. J Pharm Sci 87:787-796. (Pubitemid 28319406)
43. Zhang Q, Jiang X, Jiang W, Lu W, Su L, Shi Z. 2004. Preparation of nimodipine loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int J Pharm 275:85-96. (Pubitemid 38481522)